Parallax Volatility Advisers
VBIV

Parallax Volatility Advisers’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Parallax Volatility Advisers’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-176
Closed -$23K – 4570
2017
Q4 		$23K Buy
+176
New +$21.6K ﹤0.01% 3627

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Parallax Volatility Advisers's VBIV Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2018, closing a stake of 176 shares — an estimated $23K sold.

Parallax Volatility Advisers first reported a position in VBIV in Q4 2017 and held it in 1 quarter. The position peaked at $23K in Q4 2017. 60 funds tracked by Wall St. Rank hold VBIV as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 176 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2018, an estimated $23K.
  • Parallax Volatility Advisers first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $23K in Q4 2017.
  • 60 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.